Cart
sales@molnova.com
LY-517717
CAS No. 313489-71-3
LY-517717( LY 517717 | LY517717 )
Catalog No. M14007 CAS No. 313489-71-3
A potent, selective, and orally bioavailable factor Xa (FXa) inhibitor for prevention and treatment of thromboembolic diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 50MG | 1782 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLY-517717
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective, and orally bioavailable factor Xa (FXa) inhibitor for prevention and treatment of thromboembolic diseases.
-
DescriptionA potent, selective, and orally bioavailable factor Xa (FXa) inhibitor for prevention and treatment of thromboembolic diseases.Thrombosis Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsLY 517717 | LY517717
-
PathwayMetabolic Enzyme/Protease
-
TargetFactor Xa
-
RecptorFactor Xa
-
Research AreaCardiovascular Disease
-
IndicationThrombosis
Chemical Information
-
CAS Number313489-71-3
-
Formula Weight459.59
-
Molecular FormulaC27H33N5O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(C1=CC2=C(C=C1)C=CN2)N[C@H](C3=CC=CC=C3)C(N4CCN(C5CCN(C)CC5)CC4)=O
-
Chemical Name(R)-N-(2-(4-(1-methylpiperidin-4-yl)piperazin-1-yl)-2-oxo-1-phenylethyl)-1H-indole-6-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kubitza D, et al. Expert Opin Investig Drugs. 2006 Aug;15(8):843-55.
2. Ahrens I, et al. Discov Med. 2012 Jun;13(73):445-50.
molnova catalog
related products
-
Dechloro Rivaroxaban
Dechloro Rivaroxaban is an orally active and highly selective Factor Xa inhibitor.Dechloro Rivaroxaban has a significant inhibitory effect on free FXa in humans.
-
Edoxaban (b)
A potent and orally active Factor Xa inhibitor with Ki of 0.561 nM.
-
Apixaban
A highly potent, selective, efficacious, and orally bioavailable inhibitor of factor Xa (FXa) with Ki of 0.08 nM; shows no affinity for thrombin (Ki>3 uM).
